Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019 On 30th December 2014
Summary The industry analysis specialist, has released its new report, “Hepatitis A Preventive Vaccines Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcare-medical/rhepatitis-a-preventive-vaccines-pipeline-assessment-and-market-forecasts-135205
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Scope The report provides information on the key drivers and challenges of the Hepatitis A Preventive Vaccines market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hepatitis A Preventive Vaccines market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Hepatitis A Preventive Vaccines market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hepatitis A Preventive Vaccines market. - Analysis of key recent licensing and partnership agreements in Hepatitis A Preventive Vaccines market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Hepatitis A Preventive Vaccines market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hepatitis A Preventive Vaccines market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Hepatitis A Preventive Vaccines market landscape? – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Hepatitis A Introduction 2.1 Disease Overview 2.2 Epidemiology 2.2.1 Historical Vaccination Coverage (2006-2011) 2.2.2 Forecast Vaccination Coverage (2011-2019) 2.3 Prognosis Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.4 Etiology 2.5 Pathophysiology 2.6 Signs and Symptoms 2.7 Diagnosis 2.8 Treatment and Management Options 2.9 Referral Pathway 2.10 GlobalData Pipeline Report Guidance 3 Hepatitis A Preventive Vaccines - Market Characterization 3.1 Global Hepatitis A Preventive Vaccines Market Size (2006-2011) 3.2 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Global 3.3 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The US 3.4 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The US 3.5 Hepatitis A Preventive Vaccines Market Size (2006-2011) - France 3.6 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - France 3.7 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Germany 3.8 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Germany 3.9 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Italy 3.10 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Italy 3.11 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Spain 3.12 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Spain 3.13 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The UK 3.14 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The UK 3.15 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Japan 3.16 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Hepatitis A Preventive Vaccines Market 3.17.1 Drivers for the Hepatitis A Preventive Vaccines Market 3.17.2 Barriers for the Hepatitis A Preventive Vaccines Market 3.18 Opportunity and Unmet Need Analysis 3.19 Key Takeaway 4 Hepatitis A Preventive Vaccines - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed class of Products in the Hepatitis A Market 4.3.1 Havrix 4.3.2 Vaqta 4.3.3 Twinrix Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
4.3.4 Ambirix 4.3.5 Avaxim 4.3.6 Epaxal 4.4 Key Takeaway 5 Hepatitis A Preventive Vaccines - Clinical Trials Mapping 5.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 5.2 Clinical Trials by Phase 5.3 Clinical Trials by Trial Status 5.4 Prominent Sponsors 5.5 Clinical Trials by Overall Sponsors 5.6 Top Companies Participating in Hepatitis A Preventive Vaccines Clinical Trials 6 Hepatitis A Preventive Vaccines - Strategic Assessment 6.1 Key Events Impacting the Future Market 6.2 Hepatitis A Preventive Vaccines: Implications for Future Market Competition 7 Hepatitis A Preventive Vaccines - Future Players 7.1 Introduction 7.2 Company Profiles 7.2.1 GlaxoSmithKline 7.2.2 Merck & Co 7.2.3 Crucell 8 KOL Insights 9 Hepatitis A Preventive Vaccines - Appendix 9.1 Market Definitions 9.2 Abbreviations 9.3 Bibliography 9.4 Methodology 9.4.1 Coverage 9.4.2 Secondary Research 9.4.3 Forecasting 9.4.4 Primary Research 9.4.5 Expert Panel Validation 9.5 Contact Us 9.6 Disclaimer List Of Tables Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 1: Comparison between Hepatitis A, B and C Table 2: HAV Endemicity by Region Table 3: Vaccination Coverage (In Percentage) Table 4: Vaccination Coverage (In Percentage) Table 5: History and Physical Examination Table 6: Laboratory and Other Studies for Hepatitis A Table 7: Differential Diagnosis of hepatitis A Table 8: Havrix Dosage and Schedule for Vaccination Table 9: Vaqta Dosage and Schedule for Vaccination Table 10: Twinrix Dosage and Schedule for Vaccination Table 11: UK Guidelines For Hepatitis A Vaccination Table 12: Japanese Hepatitis A Vaccine, Dosage and Schedule Table 13: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 Table 14: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 Table 15 Hepatitis A Preventive Vaccines Market, The US, Revenue ($m), 2006-2011 Table 16: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 Table 17: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 Table 18: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 Table 19: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 Table 20: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 Table 21: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 Table 22: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 Table 23: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 Table 24: Hepatitis A Preventive Vaccines, Spain, Forecast ($m), 2011-2019 Table 25: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 Table 26: Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 Table 27: Hepatitis A Market, Japan, Revenue ($m), 2006-2011 Table 28: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 Table 29: Hepatitis A Preventive Vaccines - Clinical Trials by Region/ Country, 2012 Table 30: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 Table 31: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 Table 32: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 Table 33: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 Table 34: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
List Of Figures Figure 1: Prevalence of Hepatitis A Virus by Region Figure 2: Incidence of Hepatitis A, 1980-2009 Figure 3: Pathophysiology of Hepatitis A Figure 4 : Symptoms of Hepatitis A infection Figure 5: Referral Pathway for HAV Vaccination Figure 6: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan Figure 7: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 Figure 8: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 Figure 9 Hepatitis A Preventive Vaccines, The US, Revenue ($m), 2006-2011 Figure 10: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 Figure 11: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 Figure 12: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 Figure 13: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 Figure 14: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 Figure 15: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 Figure 16: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 Figure 17: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 Figure 18: Hepatitis A Preventive Vaccines Market, Spain, Forecast ($m), 2011-2019 Figure 19: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 Figure 20 : Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 Figure 21 : Hepatitis A Preventive Vaccines Market, Japan, Revenue ($m), 2006-2011 Figure 22: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 Figure 23: Opportunity and Unmet Need in the Hepatitis A Preventive Vaccines Market, 2012 Figure 24: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan Figure 25: Hepatitis A Preventive Vaccines - Strategic Competitor Assessment, 2012 Figure 26: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan Figure 27: Hepatitis A Preventive Vaccines - Clinical Trials by Country, 2012 Figure 28: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 Figure 29: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 Figure 30: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 Figure 31: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 Figure 32: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012 Figure 33: Hepatitis A Preventive Vaccines Market - Drivers and Restraints 2012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 34: Implications for Future Market Competition in Hepatitis A Preventive Vaccines Market, 2012 Figure 35: Hepatitis A Preventive Vaccines - Marketed Products by Company, 2012 Figure 36: KOL Insights, Hepatitis A Preventive Vaccines, Major Market Figure 37: GlobalData Market Size Estimation Figure 38 : GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Methicillin-resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Addison’s Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-hepatitis-apreventive-vaccines-pipeline-assessment-and-market-forecasts-135205
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/